Last updated on May 2020

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

Clinical Study Identifier: NCT03524092

Find a site near you

Start Over

Royal Melbourne Hospital

Parkville, Australia
  Connect »

The Alfred Hospital

Melbourne, Australia
  Connect »

The Northern Hospital

Epping, Australia
  Connect »